Andy Grove backs an engineer’s approach to medicine
05/18/10 The New York Times — Andrew S. Grove, the former chief executive of Intel, is taking the next step in his quest to infuse the engineering discipline of Silicon Valley into the development of new medical treatments. Mr. Grove has pledged $1.5 million so that the University of California campuses in San Francisco and Berkeley can start a joint master's degree program aimed at so-called translational medicine -- the process of turning biological discoveries into drugs and medical devices that can help patients.